Download as pdf or txt
Download as pdf or txt
You are on page 1of 2

SilenCircleTM Complete RNAi

Expression Kit

S ilenCircleTM RNAi system (pro-


tected under US patent 7,294,504
and additional patents pending) is
Box 1 | Product Summary

a plasmid-based RNA interference Catalogue Numbers ABP-RI-SC01010


system that uses engineered human ABP-RI-SC01020
U6 RNApolymerase III promoter and Components pre-cut pSIlenCircle Vector (10ng/µl)
modified terminator for high level pSilenCircle sequencing Primer (20µM)
small hairpin RNA (shRNA) or siRNA p53-top (coding for p53 RNAi insert top strand)
expression inside mammalian cells. (20µM)
The design enables precise start and p53-bot (coding for p53 RNAi insert bottom
end of an interfering RNA with the strand) (20µM)
optimal 3’ overhanging nucleotides. Annealing Buffer (10X)
The pre-cut linear vector is ready-to- hcT4 DNA Ligase with 10X Buffer
ligate for construction of interfering AvantGene
RNA expression plasmid with nearly DNA Diluent
zero self-ligation. Bearing a neomycin p53-5’ PCR Primer (20µM)
resistant marker, it may be used for p53-3’ PCR Primer (20µM)
establishing siRNA-expressing stable Actin-5’ PCR Primer (20µM)
cell lines. SilenCircle RNAi system Actin-3’ PCR Primer (20µM)
has been successfully used to knock- Storage Store the AvantGene at +4°C. All other rea-
down expression of both endogenous gents to be stored at -20°C.
and exogenous genes.
Stability All components are stable for 6 months when
Features stored properly.

T he SilenCircletm Complete RNAi


kit is suitable for RNAi experi-
ments in tissue culture cells. Each Reagents Provided with Design of Inserts
batch of reagents is vigorously tested
for consistency and stability, and offer the Kit
siRNA may be produced from two
the following features:
T he kit provides enough reagents pSilenCircle plasmids encoding either
- Efficient RNA interference to construct 10 RNAi expressing sense or antisense. Alternatively,
- Convenient ready-to-ligate format plasmids, including Allele recom- shRNA or miRNA may be produced
- Almost no background ligation binant high concentration T4 DNA from a single plasmid (shown below).
ligase (hcT4 DNA ligase). DNA oligos For each siRNA insert, two comple-
- Without introducing extra bases
encoding each RNAi target sequence mentary synthetic DNA oligos are
from restriction enzyme sites,
need to be designed according to the needed.
generate precise shRNA, siRNA, or
miRNA. guidelines listed below.
Choose a target region that is A2N19
Oligos for generating p53-specific (sense sequence of the target RNA),
Materials Not Suppplied design a linker sequence (e.g. 9
RNAi cassettes that have been tested
with the Kit to significantly reduce p53 mRNA bases), use the following format:
levels are also included as positive
control. 5’ acacc N19 Linker N’19 t 3’
-Target-specific insert DNA oligos 3’ g N’19 rcLinker N19 aaaaa 5’ #
-E. coli competent cells
The Complete Kit also provides
-Plasmid DNA purification system “N’19” is reverse/complementary to
AvantGeneTM transfection reagent,
-RNA purification system and reverse “N19”; “rclinker” is reverse/ comple-
suitable for most mammalian cells
transcription enzyme. mentary to “linker”.
with exceptional efficiency. RT-PCR
primers for detecting p53 and actin
# Oligos orders are typically entered
F or Research Use Only. Not for
Diagnostic or Therapeutic Use.
Purchase does not include or carry
mRNA levels are also included in the
Complete Kit. A successful p53 RNAi
from 5’ to 3’, i.e. aaaaa N19...
experiment is expected to result in Note: This product may be protected
any right to resell or transfer this reduced p53 mRNA levels while not
product either as a stand-alone under US patent 7,294,504 and additional
product or as a component of another
affecting actin mRNA levels. RT-PCR pending patents. Purchasing of this prod-
product. Any use of this product other with p53 primers should generate a uct grants the rights of use. Commercial
than the permitted use without the band of 496 bp; RT-PCR with actin user may be required to obtain further
express written authorization of Allele primers results in a band of 587b. license from third parties in order to use
certain RNA interference related technolo-
Biotech is strictly prohibited
gies.

Allele Biotech-Introducing Cost Effectiveness to Research


Protocols
Cloning Transfection
Oligo DNA annealing, ligation into the linearized vector, E. Cells are prepared and transfected generally as you
coli transformation, and plasmid DNA preparation may be would with a typical expression plasmid transfection. Most
performed according to standard protocols. Plasmid DNA commercial transfection reagents may be used with the
from positive clones will be cut only once by restriction SilenCircleTM plasmids. Although using AvantGene trans-
enzyme Stu I on the plasmid backbone (The Stu I site in fection reagent is recommended, in many cases the choice
the Polylinker should have been deleted from the pre-cut of transfection reagent should depend on cells to be used.
vector). A self-ligation plasmid (from the very few molecules Use 0.5 μg plasmid DNA per well of a 24-well plate as a
that escaped linearization of the vector) will yield two bands starting point.
of 1.1 kb and 3.5 kb, respectively. A sequencing primer is
also included in the kit for positive clone verification. Using AvantGene
Suggested Protocol for siRNA Insert Prepa- * All Volumes are for each well of 24-well plate:
ration
1. Plate cells approximately 24 hours prior to transfection
Top oligo 1μg at a cell density of 20-40% confluence in complete medium
(with serum and antibiotics if required).
Bottom Oligo 1μg
Annealing Buffer (10X) 2μl 2. Mix 2.5 μl AvantGene reagent to 10 μl serum free, antibi-
Distilled Water 20μl otics-free medium, incubate 5-10 min at room temperature.

Heat at 95°C for 10min, slowly cool down to room tempera- 3. Add 12.5 μl DNA Diluent to 0.5 μg DNA, incubate 1-5
ture. min at room temperature. Do not incubate longer than 5
min.
Suggested Protocol for DNA Ligation Using
Allele’s hcT4 DNA Ligase 4. While waiting, change cell medium to 200 μl serum-free
Pre-Cut Vector (ng/μl) 2μl and antibiotics-free medium.
Annealed insert 2μl 5. Mix diluted transfection reagent from Step 2 with DNA
Ligand buffer (10) 1μl solution from Step 3, incubate at room temperature for 5-10
T4 DNA ligase 0.5μl min.

Distilled water 4.5μl 6. Add the transfection mixture from step 5 drop-wise to
cells.
Incubate at room temperature for an hour or at 4-16°C
overnight. 7. After 2-4 hours incubation under appropriate condi-
tions in an incubator, add 250 μl serum-containing normal
medium.
Method Overview

Website: www.allelebiotech.com
Call: 1-800-991-RNAi/858-587-6645
(Pacific Time: 9:00AM~5:00PM)
Email: oligo@allelebiotech.com

Allele Biotech-Introducing Cost Effectiveness to Research

You might also like